Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FLOW Trial: Fluoxetine to Open the Critical Period Time Window to Improve Motor Recovery After Stroke

NCT03448159 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03448159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03448159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FLOW Trial: Fluoxetine to Open the Critical Period Time Window to Improve Motor Recovery After Stroke
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
January 1, 2019
Completion date
September 30, 2022
Enrollment
52 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

brain diseases, brain infarction, brain ischemia, central nervous system diseases, cerebral infarction, cerebrovascular accident, cerebrovascular disorders, nervous system diseases, stroke, vascular diseases